These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2469736)
1. Immunohistochemical demonstration of age-related deposition of vitronectin (S-protein of complement) and terminal complement complex on dermal elastic fibers. Dahlbäck K; Löfberg H; Alumets J; Dahlbäck B J Invest Dermatol; 1989 May; 92(5):727-33. PubMed ID: 2469736 [TBL] [Abstract][Full Text] [Related]
2. Vitronectin colocalizes with Ig deposits and C9 neoantigen in discoid lupus erythematosus and dermatitis herpetiformis, but not in bullous pemphigoid. Dahlbäck K; Löfberg H; Dahlbäck B Br J Dermatol; 1989 Jun; 120(6):725-33. PubMed ID: 2474318 [TBL] [Abstract][Full Text] [Related]
3. Deposition of C3, C9 neoantigen and vitronectin (S-protein of complement) in lichen planus pemphigoides. Hintner H; Sepp N; Dahlbäck K; Dahlbäck B; Fritsch P; Breathnach SM Br J Dermatol; 1990 Jul; 123(1):39-47. PubMed ID: 1697188 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical studies on vitronectin in elastic tissue disorders, cutaneous amyloidosis, lichen ruber planus and porphyria. Dahlbäck K; Löfberg H; Dahlbäck B Acta Derm Venereol; 1988; 68(2):107-15. PubMed ID: 2453988 [TBL] [Abstract][Full Text] [Related]
5. Middermal elastolysis. Report of a case and immunohistochemical studies on the dermal distribution of fibrillin, vitronectin and amyloid P component. Thörneby K; Sakai L; Dahlbäck K Acta Derm Venereol; 1991; 71(1):1-5. PubMed ID: 1711751 [TBL] [Abstract][Full Text] [Related]
6. Vitronectin in mouse skin: immunohistochemical demonstration of its association with cutaneous amyloid. Dahlbäck K; Wulf HC; Dahlbäck B J Invest Dermatol; 1993 Feb; 100(2):166-70. PubMed ID: 7679136 [TBL] [Abstract][Full Text] [Related]
7. Localization of vitronectin (S-protein of complement) in normal human skin. Dahlbäck K; Löfberg H; Dahlbäck B Acta Derm Venereol; 1986; 66(6):461-7. PubMed ID: 2433863 [TBL] [Abstract][Full Text] [Related]
8. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. Bhakdi S; Käflein R; Halstensen TS; Hugo F; Preissner KT; Mollnes TE Clin Exp Immunol; 1988 Dec; 74(3):459-64. PubMed ID: 2466593 [TBL] [Abstract][Full Text] [Related]
9. Formation of the terminal complement complex on agarose beads: further evidence that vitronectin (complement S-protein) inhibits C9 polymerization. Johnson E; Berge V; Høgåsen K Scand J Immunol; 1994 Mar; 39(3):281-5. PubMed ID: 7510414 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of vitronectin in association with elastin and amyloid deposits in human kidney. Dahlbäck K; Löfberg H; Dahlbäck B Histochemistry; 1987; 87(6):511-5. PubMed ID: 2447039 [TBL] [Abstract][Full Text] [Related]
11. Fibrillin immunoreactive fibers constitute a unique network in the human dermis: immunohistochemical comparison of the distributions of fibrillin, vitronectin, amyloid P component, and orcein stainable structures in normal skin and elastosis. Dahlbäck K; Ljungquist A; Löfberg H; Dahlbäck B; Engvall E; Sakai LY J Invest Dermatol; 1990 Mar; 94(3):284-91. PubMed ID: 1689758 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy. Ogawa T; Yorioka N; Yamakido M Nephron; 1994; 68(1):87-96. PubMed ID: 7527506 [TBL] [Abstract][Full Text] [Related]
13. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9. Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159 [TBL] [Abstract][Full Text] [Related]
14. Decay-accelerating factor in human skin is associated with elastic fibers. Werth VP; Ivanov IE; Nussenzweig V J Invest Dermatol; 1988 Nov; 91(5):511-6. PubMed ID: 2459267 [TBL] [Abstract][Full Text] [Related]
15. SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules. Preissner KP; Podack ER; Müller-Eberhard HJ Eur J Immunol; 1989 Jan; 19(1):69-75. PubMed ID: 2465906 [TBL] [Abstract][Full Text] [Related]
16. Quantitation of activation of the human terminal complement pathway by ELISA. Sanders ME; Schmetz MA; Hammer CH; Frank MM; Joiner KA J Immunol Methods; 1985 Dec; 85(2):245-56. PubMed ID: 2416846 [TBL] [Abstract][Full Text] [Related]
17. [Vitronectin in normal human skin and in skin lesions]. Hintner H; Breathnach SM; Dahlbäck K; Dahlbäck B; Fritsch P Hautarzt; 1991 Jan; 42(1):16-22. PubMed ID: 1707041 [TBL] [Abstract][Full Text] [Related]
18. Tissue vitronectin in normal adult human dermis is non-covalently bound to elastic tissue. Hintner H; Dahlbäck K; Dahlbäck B; Pepys MB; Breathnach SM J Invest Dermatol; 1991 May; 96(5):747-53. PubMed ID: 1708799 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies. Kemp PA; Spragg JH; Brown JC; Morgan BP; Gunn CA; Taylor PW J Clin Lab Immunol; 1992; 37(4):147-62. PubMed ID: 1285067 [TBL] [Abstract][Full Text] [Related]
20. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]